Background: Glossina fuscipes fuscipes is the main vector of African Trypanosomiasis affecting both humans and livestock in Uganda. The human disease (sleeping sickness) manifests itself in two forms: acute and …
Tuberculosis and tobacco are responsible for nearly 1.4 and 8 million deaths globally per year respectively. By 2030, the WHO projects that 80% of the global deaths from tobacco will …
Introduction. Certain oral manifestations signal progression of HIV disease among HAART naïve patients or an increase inthe plasma HIV-1 RNA levels for those on treatment. Ranulas may be one of …
Objectives: To compare the degree of pain, efficacy and safety of pelvic plexus block to otherconventional techniques of analgesia in 12 core transrectal ultrasound guided biopsy of prostate.Materials and Methods: …
ObjectiveâTo evaluate pre-exposure prophylaxis (PrEP) efficacy for HIV-1 prevention amongwomen using depot medroxyprogesterone acetate (DMPA) for contraception and men whoseHIV-1 infected partners use DMPA.DesignâSecondary analysis of data from a randomized …
Adolescents living with HIV (ALHIV) are prone to depression, which can have detrimental effects including disease progression, poor treatment adherence and mortality. We aimed to determine the prevalence of depressive …
MEDLINE Abstract: INTRODUCTION: Pre-eclampsia, which is more prevalent in resource-limited settings, contributes significantly to maternal, fetal and neonatal morbidity and mortality. However, the factors associated with these adverse outcomes are …
Compares safety and antiretroviral effect of current standard ART to once daily intergrase inhibitor (INSTI) administered with darunavir/ritonavir (DRV/r) in HIV-1 infected, virologically suppressed children.This ongoing two arm, phase 2/3 …
This is a Household-based outreach and patient engagement cross sectional survey targeted to increase TB and HIV case finding among household TB contacts of index TB patients through active contact …
BACKGROUND AND AIMS: Major adverse cardiac events (MACE) remain a leading cause of mortality in chronic kidney disease (CKD). Apabetalone is an orally available inhibitor of bromodomain & extraterminal (BET) …